SPBC582.10c Antibody

What is SPBC582.10c Antibody and what organism does it target?

SPBC582.10c Antibody is a polyclonal antibody raised in rabbits that specifically targets the SPBC582.10c protein from Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The antibody is generated using recombinant S. pombe SPBC582.10c protein as the immunogen and is purified through antigen affinity methods to ensure specificity. This IgG isotype antibody is designed specifically for research applications involving fission yeast models and should not be used for diagnostic or therapeutic applications .

What are the validated experimental applications for SPBC582.10c Antibody?

The SPBC582.10c Antibody has been validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications. These techniques allow researchers to detect and quantify SPBC582.10c protein in various experimental contexts. The antibody's specificity for its target has been confirmed through appropriate validation tests to ensure proper identification of the antigen. When designing experiments, researchers should consider that this antibody has not been validated for other applications such as immunohistochemistry, immunoprecipitation, or flow cytometry without further testing .

What are the recommended storage conditions to maintain antibody functionality?

For optimal preservation of antibody activity, SPBC582.10c Antibody should be stored at either -20°C or -80°C upon receipt. The antibody is provided in a liquid form containing 50% glycerol and 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as a preservative. This formulation helps maintain stability during storage. Researchers should avoid repeated freeze-thaw cycles as this can lead to antibody degradation and reduced performance in experimental applications. For experiments requiring multiple uses, it is advisable to prepare small aliquots before freezing to minimize freeze-thaw cycles .

How should researchers optimize Western blot protocols for SPBC582.10c Antibody?

When optimizing Western blot protocols for SPBC582.10c Antibody, researchers should begin with a methodical approach:

• Sample preparation: Extract proteins from S. pombe using appropriate lysis buffers that maintain protein integrity while disrupting yeast cell walls. Consider including protease inhibitors to prevent degradation.

• Concentration determination: Begin with a dilution range of 1:500 to 1:2000 of the antibody to determine optimal concentration. Too high a concentration may lead to background signals, while too low may result in weak signals.

• Blocking optimization: Use 5% non-fat dry milk or BSA in TBST for blocking. Compare both to determine which provides better signal-to-noise ratio with this specific antibody.

• Incubation conditions: Test both overnight incubation at 4°C and 1-2 hour incubation at room temperature to determine optimal binding conditions.

• Control experiments: Include positive controls using recombinant SPBC582.10c protein and negative controls using non-specific IgG to validate specificity.

The optimization should follow similar principles used in antibody development frameworks like those documented in various antibody design studies .

What cross-reactivity concerns should researchers address when using this antibody?

When working with SPBC582.10c Antibody, researchers should systematically address potential cross-reactivity issues:

• Sequence homology analysis: Conduct bioinformatic analysis to identify proteins with similar sequences to SPBC582.10c in your experimental system. This is particularly important when working with related yeast species or when examining conserved protein families.

• Pre-absorption controls: If cross-reactivity is suspected, perform pre-absorption experiments by incubating the antibody with purified recombinant SPBC582.10c protein before applying to samples.

• Knockout validation: Where possible, include samples from SPBC582.10c knockout strains as negative controls to confirm specificity.

• Competitive binding assays: Implement competitive binding experiments using free SPBC582.10c protein, similar to methods used in antibody specificity studies for other targets .

• Database cross-referencing: Consult antibody databases like PLAbDab to examine patterns of cross-reactivity for similarly structured antibodies against related targets .

What experimental controls are essential when using SPBC582.10c Antibody in immunoassays?

For rigorous experimental design using SPBC582.10c Antibody, the following controls are essential:

• Positive control: Include purified recombinant SPBC582.10c protein or lysates from wild-type S. pombe known to express the target protein.

• Negative control: Use samples from SPBC582.10c knockout strains or species lacking homologous proteins.

• Isotype control: Include experiments with non-specific rabbit IgG at the same concentration to identify potential non-specific binding.

• Loading controls: For Western blotting, use antibodies against housekeeping proteins (e.g., actin) to normalize protein loading.

• Secondary antibody-only control: Perform reactions with secondary antibody alone to detect potential direct binding to samples.

• Antigen competition assay: Pre-incubate the antibody with excess target protein to demonstrate that binding is specifically inhibited.

These controls align with rigorous validation methods used in antibody research databases like PLAbDab, which emphasizes the importance of functional characterization in antibody validation .

How can researchers address high background signals when using SPBC582.10c Antibody?

When encountering high background signals with SPBC582.10c Antibody, implement this methodological approach:

• Increase blocking stringency: Extend blocking time to 2 hours and test different blocking agents (milk, BSA, commercial blockers) to identify optimal conditions.

• Adjust antibody concentration: Create a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) to identify the optimal concentration that maintains specific signal while reducing background.

• Modify washing protocol: Increase the number of washes (5-6 times) and duration (10 minutes each) with fresh TBST or PBST buffer.

• Add detergent or carrier proteins: Incorporate 0.1-0.5% Tween-20 or 0.1-1% BSA to the antibody dilution buffer to reduce non-specific binding.

• Optimize incubation conditions: Compare room temperature incubation for 1-2 hours versus 4°C overnight to determine which provides better signal-to-noise ratio.

• Pre-absorb antibody: Incubate with non-specific proteins from the sample species to remove antibodies that might bind non-specifically.

These troubleshooting methods align with approaches used in computational antibody design frameworks, which emphasize the importance of optimizing binding specificity .

What strategies can researchers employ when SPBC582.10c Antibody shows weak or no signal?

When experiencing weak or absent signals with SPBC582.10c Antibody, researchers should implement this systematic troubleshooting approach:

• Sample preparation optimization:

  • Verify protein extraction efficiency from S. pombe cells

  • Use multiple lysis methods (mechanical disruption, enzymatic treatment) to ensure complete protein extraction

  • Include protease inhibitors to prevent target degradation

  • For membrane-associated proteins, ensure appropriate detergents are used

• Antibody handling verification:

  • Check for antibody degradation with dot blot analysis

  • Avoid excessive freeze-thaw cycles

  • Ensure proper storage conditions (-20°C or -80°C)

• Detection system enhancement:

  • Use high-sensitivity ECL substrates for Western blotting

  • Consider amplification systems like biotin-streptavidin

  • Optimize exposure time for Western blot imaging

  • Use fresh detection reagents

• Antigen retrieval for fixed samples:

  • Test different antigen retrieval methods if working with fixed cells

  • Optimize fixation protocols to preserve epitope accessibility

• Epitope accessibility assessment:

  • Consider denaturing conditions that might expose the epitope

  • Test different detergents and reducing agents in sample buffers

These approaches draw on principles used in antibody design frameworks that emphasize the importance of epitope accessibility and binding optimization .

How can researchers validate the specificity of SPBC582.10c Antibody in their experimental system?

To rigorously validate SPBC582.10c Antibody specificity, researchers should implement multiple orthogonal approaches:

• Genetic validation:

  • Test antibody reactivity in wild-type versus SPBC582.10c knockout or knockdown S. pombe strains

  • Examine signal in strains with varying expression levels of the target protein

• Biochemical validation:

  • Perform competitive binding assays with purified recombinant SPBC582.10c protein

  • Conduct immunoprecipitation followed by mass spectrometry to identify pulled-down proteins

  • Use peptide competition assays with the immunizing antigen

• Molecular validation:

  • Examine size concordance between detected bands and predicted molecular weight

  • Test reactivity against tagged versions of the protein (FLAG, His, etc.)

  • Verify subcellular localization patterns match known distribution

• Cross-species validation:

  • Test reactivity in related yeast species with varying sequence homology

  • Examine cross-reactivity with human or other mammalian samples as negative controls

• Multiple detection methods:

  • Compare results between Western blotting and ELISA

  • If possible, validate with orthogonal methods like immunofluorescence

This multi-modal validation approach aligns with the rigorous standards used in antibody database curation, ensuring reliable research outcomes .

How can SPBC582.10c Antibody be integrated into advanced proteomics workflows?

SPBC582.10c Antibody can be strategically integrated into advanced proteomics workflows through several methodological approaches:

• Immunoprecipitation-Mass Spectrometry (IP-MS):

  • Use the antibody to pull down SPBC582.10c and associated protein complexes

  • Analyze by LC-MS/MS to identify interaction partners

  • Implement quantitative approaches like SILAC or TMT labeling to compare interaction differences under various conditions

  • Filter results against appropriate negative controls to eliminate false positives

• Proximity-dependent labeling:

  • Engineer fusion proteins combining SPBC582.10c with BioID or APEX2

  • Use the antibody to validate expression and localization of the fusion protein

  • Identify proximal interacting partners through streptavidin pulldown and MS analysis

• Chromatin Immunoprecipitation (ChIP):

  • If SPBC582.10c has suspected DNA interactions, adapt ChIP protocols using this antibody

  • Perform ChIP-seq to map genomic binding sites

  • Validate ChIP signals in knockdown/knockout models

• Spatial proteomics:

  • Use the antibody in cell fractionation studies to track protein localization

  • Combine with subcellular markers to create spatial maps of protein distribution

• Post-translational modification analysis:

  • Couple immunoprecipitation with phospho-specific or other PTM-specific detection methods

  • Use antibody pulldown followed by targeted MS to identify modified residues

These advanced applications build upon rigorous antibody validation principles described in computational antibody design frameworks and antibody databases .

What considerations are important when using SPBC582.10c Antibody in multiplexed detection systems?

When incorporating SPBC582.10c Antibody into multiplexed detection systems, researchers should address these critical methodological considerations:

• Antibody compatibility analysis:

  • Test for cross-reactivity between all antibodies in the multiplex panel

  • Verify that secondary antibodies don't cross-react with primary antibodies from different species

  • Validate that detection reagents remain specific in the multiplexed context

• Signal optimization strategies:

  • Titrate each antibody individually before combining to determine optimal concentrations

  • Test different incubation sequences to minimize interference

  • Establish distinct fluorophores or reporters with minimal spectral overlap

• Sequential staining protocols:

  • Implement multi-round staining with complete stripping between rounds

  • Validate complete stripping using appropriate controls

  • Document potential epitope degradation during stripping procedures

• Computational deconvolution methods:

  • Apply appropriate algorithms to distinguish overlapping signals

  • Implement machine learning approaches for signal classification

  • Use appropriate statistical methods to quantify co-localization

• Validation with single-plex controls:

  • Compare signals in multiplexed versus single-plex detection

  • Establish signal thresholds based on single-antibody experiments

  • Document potential signal enhancement or suppression in multiplexed formats

These considerations align with principles used in advanced antibody databases and computational antibody design frameworks, emphasizing the importance of specificity and signal optimization .

How can computational modeling enhance experimental design with SPBC582.10c Antibody?

Computational modeling can significantly enhance experimental design with SPBC582.10c Antibody through several methodological approaches:

• Epitope prediction and accessibility analysis:

  • Use structural modeling to predict the epitope recognized by the antibody

  • Analyze protein folding to determine epitope accessibility under various experimental conditions

  • Model the impact of detergents or denaturing agents on epitope exposure

• Cross-reactivity prediction:

  • Perform sequence alignment and structural comparison between the target and related proteins

  • Calculate binding energies to predict potential cross-reactivity

  • Model antibody-antigen interactions using frameworks like RosettaAntibodyDesign

• Experimental condition optimization:

  • Simulate buffer conditions and pH effects on antibody-antigen binding

  • Model temperature impacts on binding kinetics

  • Predict optimal incubation times based on binding kinetics models

• Signal interpretation frameworks:

  • Develop quantitative models to relate signal intensity to protein abundance

  • Create statistical frameworks for distinguishing specific from non-specific signals

  • Model signal-to-noise ratios under different experimental conditions

• Experiment planning algorithms:

  • Implement design of experiments (DoE) approaches to efficiently optimize multiple parameters

  • Use sensitivity analysis to identify the most critical variables in your experimental system

  • Develop decision trees for troubleshooting based on computational predictions

These computational approaches leverage frameworks similar to RosettaAntibodyDesign (RAbD), which uses structural bioinformatics for antibody design and optimization .

What statistical approaches are most appropriate for analyzing SPBC582.10c Antibody data across different experimental platforms?

When analyzing data generated using SPBC582.10c Antibody across different platforms, researchers should implement these statistical methodologies:

• Western blot quantification:

  • Normalize band intensities to loading controls using regression-based approaches

  • Apply non-parametric tests for comparing conditions with small sample sizes

  • Implement ANOVA with appropriate post-hoc tests for multi-group comparisons

  • Account for non-linearity in signal response using standard curves from recombinant protein

• ELISA data analysis:

  • Apply four-parameter logistic regression for standard curve fitting

  • Use interpolation within the linear range of the standard curve

  • Calculate coefficients of variation to assess technical replication quality

  • Implement mixed-effects models for experiments with multiple sources of variation

• Multi-experiment integration:

  • Apply meta-analysis techniques to combine data across independent experiments

  • Use standardization methods to normalize signals across different platforms

  • Implement Bayesian approaches to incorporate prior information from related studies

  • Apply dimensionality reduction techniques for visualizing complex multi-dimensional datasets

• Reproducibility assessment:

  • Calculate intraclass correlation coefficients for technical replicates

  • Use Bland-Altman plots to visualize agreement between methods

  • Implement bootstrapping to generate confidence intervals for measured parameters

  • Apply permutation tests to establish empirical significance thresholds

These statistical approaches align with rigorous methodologies used in antibody validation studies documented in antibody databases like PLAbDab .

How should researchers interpret unexpected binding patterns with SPBC582.10c Antibody?

When encountering unexpected binding patterns with SPBC582.10c Antibody, researchers should implement this systematic interpretive framework:

• Pattern characterization:

  • Document precisely how observed patterns differ from expectations

  • Quantify the reproducibility of unexpected signals across independent experiments

  • Determine whether unexpected patterns are condition-specific or consistent

• Alternative target identification:

  • Perform mass spectrometry analysis of unexpectedly detected bands/signals

  • Conduct bioinformatic analysis to identify proteins with sequence similarity to SPBC582.10c

  • Test competition assays with recombinant SPBC582.10c to distinguish specific from non-specific binding

• Post-translational modification assessment:

  • Investigate whether unexpected band sizes correspond to known PTM patterns

  • Test phosphatase or other enzymatic treatments to determine if modifications affect binding

  • Use PTM-specific antibodies to confirm modification status

• Proteolytic processing evaluation:

  • Compare observed molecular weights to predicted fragment sizes

  • Test protease inhibitor cocktails to determine if unexpected patterns are due to degradation

  • Examine literature for known processing events affecting SPBC582.10c or related proteins

• Cross-reactivity validation:

  • Test the antibody in systems where the target is absent (knockout/knockdown)

  • Perform pre-absorption experiments with purified recombinant proteins

  • Conduct epitope mapping to identify the specific binding region

This interpretive approach aligns with methodologies used in antibody specificity studies and leverages principles from computational antibody design frameworks .

What benchmarking approaches should be used to compare SPBC582.10c Antibody performance against other detection methods?

To rigorously benchmark SPBC582.10c Antibody performance against alternative detection methods, researchers should implement this comprehensive methodology:

• Orthogonal detection comparison:

  • Compare antibody-based detection with targeted mass spectrometry

  • Correlate antibody signals with RNA expression (RT-qPCR or RNA-seq)

  • Benchmark against fluorescent protein tagging approaches

  • Evaluate agreement with aptamer-based detection methods

• Performance metric quantification:

  • Calculate sensitivity (limit of detection) across methods

  • Determine dynamic range for each detection approach

  • Quantify precision using coefficients of variation

  • Measure accuracy using spike-in recovery experiments

  • Assess reproducibility across different laboratories or operators

• Systematic bias assessment:

  • Implement Bland-Altman analysis to identify systematic differences between methods

  • Use orthogonal regression to establish conversion factors between different techniques

  • Identify condition-specific discrepancies that might reveal method limitations

• Resource requirement evaluation:

  • Document time, cost, and technical expertise needed for each method

  • Assess scalability for high-throughput applications

  • Evaluate data analysis complexity and computational requirements

• Integrative analysis frameworks:

  • Develop statistical models to combine data from multiple detection methods

  • Implement Bayesian approaches to weight evidence based on method reliability

  • Create visualization tools that integrate multi-method data

This benchmarking approach draws on principles used in computational antibody design frameworks and antibody database development, emphasizing rigorous performance assessment .

Table 1: SPBC582.10c Antibody Technical Specifications

How does protein expression level in S. pombe affect detection sensitivity with SPBC582.10c Antibody?

The relationship between SPBC582.10c protein expression levels and antibody detection sensitivity follows systematic patterns that researchers should consider:

• Expression-detection relationship characterization:

  • At low expression levels (<0.01% of total protein), signal may fall below detection threshold in standard Western blots

  • Mid-range expression (0.01-0.1% of total protein) typically produces linear signal response

  • High expression levels (>0.1% of total protein) may result in signal saturation in standard exposure conditions

• Sensitivity enhancement strategies:

  • For low abundance targets, implement protein concentration methods like immunoprecipitation before detection

  • Use high-sensitivity chemiluminescent or fluorescent detection systems

  • Extend exposure times while monitoring background signal increases

  • Consider signal amplification systems like tyramide signal amplification for immunodetection

• Quantification optimization:

  • Create standard curves with recombinant SPBC582.10c protein

  • Identify the linear detection range specific to your experimental system

  • Use internal controls with known expression levels for relative quantification

  • Implement digital imaging systems with extended dynamic range

• Expression modulation approaches:

  • Consider genetic overexpression to enhance signal if detection is challenging

  • Use inducible promoters to create a range of expression levels for assay calibration

  • Employ cell synchronization to capture expression at peak levels for cyclically expressed proteins